NCT00058656View on ClinicalTrials.gov

Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

March 31, 2003

Conditions

Chronic Lymphocytic Leukemia

Interventions

PROCEDURE

Infusion of Activated & Expanded Autologous T Cells

Trial Locations (4)

20817

Center for Cancer & Blood Disorders, Bethesda

30076

Atlanta Cancer Care, Roswell

77030

MD Anderson Cancer Center, Houston

92093-0663

University of California, San Diego, San Diego

Sponsors

Lead Sponsor

Xcyte Therapies

All Listed Sponsors

lead

Xcyte Therapies

INDUSTRY

NCT00058656 - Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients | Biotech Hunter | Biotech Hunter